Covestus Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Covestus Limited - overview
Established
2018
Location
Cheltenham, -, UK
Primary Industry
Business Support Services
About
Based in Gloucestershire, UK, and founded in 2018 and led by CEO Dan Thomas, Covestus Limited engages in the acquisition and brand operation of pharmaceutical and healthcare products. Its brands include Probio7 and Sweat Guard. In July 2024, Covestus Limited raised growth funding led by Maven Capital Partners and British Business Bank's Southwest Investment Fund. Covestus Limited leverages digital technology to transform consumer healthcare marketing, offering solutions through both traditional pharmaceutical and e-commerce channels.
It operates a decentralized model, focusing on a network of specialist partners for manufacturing, regulatory compliance, and sales while maintaining central oversight to ensure quality. The company specializes in mergers, acquisitions, and licensing deals, targeting healthcare products and companies. As of 2024, it operates various brands such as Probio7 and Sweat Guard.
Primary Industry
Business Support Services
Sub Industries
Business Support Services, Financial Services, Pharmaceutical Research & Development
Website
www.covestus.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.